ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

May 31, 2013

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993

Rauscher Disappointed In CREG Progress

October 1, 1976

825,000 Pounds of Yew Bark Clleced in ’91 For 10,000 Patients

March 13, 1992